David Eyre, MA (Cantab) DPhil (Oxon) CPA EPA

Cras tempus ligula a tempor adipiscing


David’s academic background is in molecular genetics and biochemistry. He has a degree in Natural Sciences, specialising in genetics, from the University of Cambridge, which included additional studies in biochemistry, molecular cell biology, organic chemistry, mathematics and geology. David then went on to study at the University of Oxford where he was awarded a DPhil for his research on the nuclear architecture of telomeres and how changes in nuclear organisation affect recombination. Next he moved to the US and the National Cancer Institute, part of the National Institutes of Health (NIH) in Bethesda, Maryland, USA, as an International Visiting Fellow. His work at NIH included mapping the genome-wide DNA damage caused by anti-cancer chemotherapeutic drugs and screening for novel chemotherapeutic drugs, in particular topoisomerase II inhibitors. David has also worked as a staff editor at the Society for General Microbiology, in particular for the Journal of General Virology. Following moving into the patents profession, David attended Queen Mary, University of London to study for the Certificate in Intellectual Property Law, which he passed with Merit. He qualified as a European Patent Attorney in 2014 and as a Chartered Patent Attorney in 2015.

David’s practice is in filing, prosecuting and opposing patents, primarily in Europe and the UK. He also deals with matters in other jurisdictions including the USA, Japan, China and Australia. In this vein, he has prosecuted applications via International Examination under the Patent Cooperation Treaty, and via the Patent Prosecution Highway; these systems are available for more rapid and efficient grant of patents internationally. He works for a range of clients, from small companies and university spin-outs to international corporations. Similarly, he has experience in a wide variety of subject matters. In the life sciences David has particular experience in the areas of molecular genetics, cancer medicine, pharmaceuticals, stem cells, bioreactors, viral biology, microbiology, medical devices and implants, and medical imaging technologies. He also works with mechanical and engineering subject matters, notable examples being waste treatment devices, packaging for drugs, chemical handling methods and fishing.